Edition:
India

Tissue Regenix Group PLC (TRX.L)

TRX.L on London Stock Exchange

1.10GBp
11 Dec 2019
Change (% chg)

0.08 (+7.32%)
Prev Close
1.02
Open
1.02
Day's High
--
Day's Low
--
Volume
10,622,899
Avg. Vol
38,756,986
52-wk High
8.80
52-wk Low
0.45

Latest Key Developments (Source: Significant Developments)

Tissue Regenix Says Increase In Throughput Now Expected To Become Available During Q4 2019
Thursday, 17 Oct 2019 

Oct 17 (Reuters) - Tissue Regenix Group PLC ::TRADING UPDATE.INCREASE IN THROUGHPUT IS NOW EXPECTED TO BECOME AVAILABLE DURING Q4 2019.BOARD ANTICIPATES THAT REVENUE FOR 2019 WILL BE BELOW CURRENT MARKET CONSENSUS BY APPROXIMATELY 15% TO 20%.BOARD DOES NOT ANTICIPATE ANY LONGER TERM IMPACT OVER AND ABOVE APPROXIMATE THREE MONTH DELAY TO MANUFACTURING CAPACITY INCREASE.  Full Article

Woodford Investment Management Cuts Stake To 22.16% From 26% In Tissue Regenix
Monday, 8 Jul 2019 

July 8 (Reuters) - Woodford Investment Management Ltd ::WOODFORD INVESTMENT MANAGEMENT LTD CUTS STAKE TO 22.16% FROM 26% IN TISSUE REGENIX GROUP PLC -FILING.  Full Article

Tissue Regenix Expands U.S. GPO Coverage For Dermapure
Thursday, 4 Apr 2019 

April 4 (Reuters) - Tissue Regenix Group Plc ::SECURED ADDITIONAL COVERAGE WITH A US GROUP PURCHASING ORGANIZATION (GPO) FOR USE OF DERMAPURE, A DECELLULARIZED ALLOGRAFT DERMIS.  Full Article

Tissue Regenix Group Reports FY Pro Forma Revenue Growth Of 47 Pct
Monday, 4 Feb 2019 

Feb 4 (Reuters) - Tissue Regenix Group PLC ::TISSUE REGENIX GROUP PLC - FY GROUP REVENUE GROWTH OF 47% PRO FORMA AND CONSTANT CURRENCY.TISSUE REGENIX GROUP PLC - EXPECTS TO DELIVER FY REVENUE OF £11.6M (2017: £5.2M) IN LINE WITH BOARD'S EXPECTATIONS.TISSUE REGENIX GROUP PLC - YEAR END CASH POSITION AHEAD OF EXPECTATION AT £7.8M.  Full Article

Tissue Regenix Group Says CEO Steve Couldwell To Take Temporary Leave Of Absence
Thursday, 6 Dec 2018 

Dec 6 (Reuters) - Tissue Regenix Group PLC ::TISSUE REGENIX GROUP - STEVE COULDWELL, CHIEF EXECUTIVE OFFICER, WILL BE TAKING A TEMPORARY LEAVE OF ABSENCE FROM JAN 2019, PREDICTED TO LAST FOR Q1.TISSUE REGENIX GROUP - STEVE COULDWELL WILL BE TAKING A TEMPORARY LEAVE OF ABSENCE DUE TO PHYSICAL ILL HEALTH IN ORDER TO UNDERGO MEDICAL TREATMENT.TISSUE REGENIX GROUP - CHAIRMAN, JOHN SAMUEL, WILL BECOME EXECUTIVE CHAIRMAN AND GARETH JONES, WILL BECOME CHIEF OPERATING OFFICER, BOTH ON INTERIM BASIS.CURRENT TRADING FOR FY '18 REMAINS IN LINE WITH BOARD EXPECTATIONS.  Full Article

Tissue Regenix Group Appoints Gareth Hywel Jones CFO
Wednesday, 4 Jul 2018 

July 4 (Reuters) - Tissue Regenix Group PLC ::APPOINTMENT OF CFO.APPOINTMENT OF GARETH HYWEL JONES AS CHIEF FINANCIAL OFFICER.GARETH HYWEL JONES WILL JOIN GROUP AS CFO, COMPANY SECRETARY AND AS AN EXECUTIVE DIRECTOR ON BOARD ON NOV 30.  Full Article

Tissue Regenix FY ‍Revenues 5.2 Mln Stg Versus 1.4 Mln Stg In 2016
Monday, 26 Mar 2018 

March 26 (Reuters) - Tissue Regenix Group Plc ::FY ‍REVENUES £5.2M VERSUS £1.4M​ IN 2016.FY ‍GROSS PROFIT £2.6M VERSUS £0.7M​ IN 2016.FY ‍OPERATING LOSS £10.8M VERSUS LOSS OF £11.1M​ IN 2016.‍EXPECT TO REPORT POSITIVE ADVANCES WITH CELLRIGHT PORTFOLIO DURING 2018​.  Full Article